One step closer to the perfect crop plant

July 04

DuPont completes purchase of Maxygen subsidiary Verdia

June 04

DuPont to acquire Maxygen subsidiary Verdia

Maxygen subsidiary Verdia announces discovery and improvement of glyphosate tolerance gene

April 03

Maxygen reports strong first quarter 2003 financial results

February 03

Maxygen reports strong fourth quarter and year end 2002 financial results

October 02

MaxyAg announces name change to Verdia, Inc. -- DeltaMax joint venture moves cotton product candidate forward into development

July 02

Maxygen reports second quarter 2002 financial results

May 02

Delta and Pine Land announces joint venture with Maxygen to develop genetically enhanced traits for cotton

February 02

Maxygen reports fourth quarter and year end 2001 financial results

November 01

Maxygen delivers to Syngenta AG two agriculture product candidates for development -- Company exceeds product development goals for 2001 (3949)

September 01

Maxygen creates novel protein activity for new market opportunities (3808)

December 00

Maxygen delivers lead agriculture development candidate (3214)

October 00

Maxygen announces two-year extension of collaboration with Pioneer Hi-Bred (3032)

August 00

Maxygen reports 2000 second quarter financial results (2918)

February 00

Maxygen appoints George Poste to its Board of Directors and announces additions to senior
management (2486)

January 00

Maxygen announces bioprocess development collaboration with Rio Tinto (2415)

August 99

Maxygen announces strategic partnership with Zeneca Agrochemicals (2054)

April 99

Maxygen obtains exclusive license to Caltech 'StEP' directed evolution technology (N1782)

January 99

Maxygen and Pioneer Hi-Bred announce strategic ag-biotech collaboration (N1477)
.

Maxygen, Inc., headquartered in Redwood City, California, is focused on creating novel products using its integrated proprietary technologies for human therapeutics and industrial applications. Maxygen's technologies bring together advances in molecular biology and protein modification to create novel biotechnology products.